[go: up one dir, main page]

PL2640364T3 - Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych - Google Patents

Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych

Info

Publication number
PL2640364T3
PL2640364T3 PL11796758T PL11796758T PL2640364T3 PL 2640364 T3 PL2640364 T3 PL 2640364T3 PL 11796758 T PL11796758 T PL 11796758T PL 11796758 T PL11796758 T PL 11796758T PL 2640364 T3 PL2640364 T3 PL 2640364T3
Authority
PL
Poland
Prior art keywords
medicament
prevention
treatment
pharmaceutical composition
related diseases
Prior art date
Application number
PL11796758T
Other languages
English (en)
Inventor
Caroline Roussel-Maupetit
Luc-André Granier
Catherine Guittet
Original Assignee
Advicenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44168791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2640364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advicenne filed Critical Advicenne
Publication of PL2640364T3 publication Critical patent/PL2640364T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11796758T 2010-11-18 2011-11-18 Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych PL2640364T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1059472A FR2967577B1 (fr) 2010-11-18 2010-11-18 Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
PL2640364T3 true PL2640364T3 (pl) 2017-09-29

Family

ID=44168791

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11796758T PL2640364T3 (pl) 2010-11-18 2011-11-18 Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych

Country Status (9)

Country Link
US (1) US9662296B2 (pl)
EP (1) EP2640364B9 (pl)
JP (1) JP5879358B2 (pl)
DK (1) DK2640364T3 (pl)
ES (1) ES2622503T3 (pl)
FR (1) FR2967577B1 (pl)
HU (1) HUE032753T2 (pl)
PL (1) PL2640364T3 (pl)
WO (1) WO2012066256A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434457A (zh) * 2014-09-23 2016-03-30 中山未标生物新技术有限公司 一种用于防治消化道癌性病变的肠溶口服制剂及其制备方法和其应用
JP6213591B2 (ja) 2016-02-25 2017-10-18 第一精工株式会社 コネクタ
JP6792848B2 (ja) * 2018-05-25 2020-12-02 国立大学法人 琉球大学 代謝改善剤
US20220273587A1 (en) * 2019-07-18 2022-09-01 C. Lowell Parsons Alkalization of urinary bladder wall prior to treatment with intravesical heparin and alkalinized lidocaine to enhance relief of bladder pain symptoms
CN111228239B (zh) * 2020-01-13 2022-04-22 厦门金达威生物科技有限公司 一种pH敏感型凝胶微胶囊及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
GB2130087A (en) 1982-09-22 1984-05-31 Dr Joachime Helbig Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
EP1970066A1 (de) * 2007-03-12 2008-09-17 Medice Arzneimittel Pütter GmbH & Co. KG Pharmazeutische Zusammensetzung zur Behandlung einer Übersäuerung des Blutes
SI2273985T1 (sl) * 2008-03-28 2016-06-30 Ferrer Internacional, S.A. Kapsula za preprečevanje kardiovaskularnih bolezni
EP2285352A2 (en) * 2008-05-13 2011-02-23 Dr. Reddy's Laboratories Ltd. Atorvastatin compositions

Also Published As

Publication number Publication date
FR2967577B1 (fr) 2013-07-12
EP2640364B9 (fr) 2017-08-30
US9662296B2 (en) 2017-05-30
DK2640364T3 (en) 2017-05-01
EP2640364B1 (fr) 2017-01-18
EP2640364A1 (fr) 2013-09-25
JP5879358B2 (ja) 2016-03-08
FR2967577A1 (fr) 2012-05-25
JP2013542974A (ja) 2013-11-28
HUE032753T2 (en) 2017-10-30
WO2012066256A1 (fr) 2012-05-24
US20130230590A1 (en) 2013-09-05
ES2622503T3 (es) 2017-07-06

Similar Documents

Publication Publication Date Title
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
IL249165A0 (en) Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
ZA201209289B (en) Urea derivatives and their therapeutic use in the treatment of,inter alia,diseases of the respiratory tract
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
ZA201104011B (en) Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
IL232325A0 (en) 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease
GB2548034B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
IL251543B (en) Use of gel compounds in the production of medicine to prevent or treat skin diseases
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
IL218277B (en) Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection
GB2497453B8 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
IL226373A (en) Pharmaceutical preparation containing citrate and bicarbonate salts and its use in the treatment of urinary cystine
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
PL2640364T3 (pl) Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych
PT2603238E (pt) Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo
IL218008A (en) Dexbinol or its salt for non-melanoma cancer suppression, its use in the preparation of non-melanoma cancer suppressant, and a pharmacological preparation containing the said
WO2011113000A8 (en) Novel ester containing compositions and methods